Lisata Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Lisata Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- LSTA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000320017
Board of directors
-
Cynthia Louise Flowers · DirectorSince 2023
-
David J. Mazzo · Director · President & CEOSince 2023
-
David W. Slack · Director · President & CBOSince 2023
-
Erkki Ruoslahti · DirectorSince 2023
-
Gregory B. Brown · DirectorSince 2023
-
Heidi Henson · DirectorSince 2023
-
Mohammad Azab · DirectorSince 2023
-
Steven M. Klosk · DirectorSince 2023
Chief executives
David J. Mazzo
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 4 other boards.
- via Gregory B. Brown
- via Heidi Henson
- via Heidi Henson
- via Mohammad Azab
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | David J. Mazzo Director, Officer (President & CEO) | Grant or award | +81,000 | — | — |
| Jan 9, 2026 | Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) | Grant or award | +15,000 | — | — |
| Jan 9, 2026 | Imam Tariq Officer (SVP, Bus Dev, General Counsel) | Grant or award | +15,000 | — | — |
| Jan 9, 2026 | Buck Kristen K Officer (EVP, R&D and CMO) | Grant or award | +25,000 | — | — |
| Jan 9, 2026 | Steven M. Klosk Director | Grant or award | +30,456 | — | — |
| Jan 9, 2026 | Heidi Henson Director | Grant or award | +30,456 | — | — |
| Jan 9, 2026 | Cynthia Louise Flowers Director | Grant or award | +30,456 | — | — |
| Jan 9, 2026 | Gregory B. Brown Director | Grant or award | +30,456 | — | — |
| Jan 9, 2026 | Mohammad Azab Director | Grant or award | +30,456 | — | — |
| Jan 9, 2026 | David J. Mazzo Director, Officer (President & CEO) | Shares withheld for tax | −10,503 | $1.97 | $20,691 |
| Jan 9, 2026 | Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) | Shares withheld for tax | −2,131 | $1.97 | $4,198 |
| Jan 9, 2026 | Imam Tariq Officer (SVP, Bus Dev, General Counsel) | Shares withheld for tax | −1,401 | $1.97 | $2,760 |
| Jan 9, 2026 | Buck Kristen K Officer (EVP, R&D and CMO) | Shares withheld for tax | −2,982 | $1.97 | $5,875 |
| Jan 9, 2026 | David J. Mazzo Director, Officer (President & CEO) | Shares withheld for tax | −10,515 | $1.97 | $20,715 |
| Jan 9, 2026 | Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) | Shares withheld for tax | −2,131 | $1.97 | $4,198 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.